Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

sRNAlytics

sRNAlytics
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
$200K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of a proprietary software platform intended to classify patient samples with binary accuracy. The company's software identifies small RNA biomarkers and the products created address an immediate need to incorporate biomarkers into drug development to satisfy FDA requirements and de-risk programs, enabling clients to identify custom biomarker panels and to meet their specific needs.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Social/Platform Software
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 479 Jessie Street
  • San Francisco, CA 94103
  • United States

+1 (201) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore sRNAlytics’s full profile, request a free trial.

sRNAlytics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 14-Nov-2017 $200K 00000 00.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

sRNAlytics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
SOSV Venture Capital Minority 000 0000 000000 0

sRNAlytics Executive Team (3)

Name Title Board
Seat
Contact
Info
David Salzman Ph.D Founder & Chief Executive Officer
Alan Salzman Ph.D Chief Operating Officer
Nathan Ray Chief Technology Officer